References
- Spencer RC. Prevalence studies in nosocomial infec-tions. Eur J Clin Microbiol Infect Dis 1992; 11, 2: 95–8.
- Coello R, Glenister H, Foreres J, Bartlet C, Leigh D, Sedgwick J, Cooke EM. The cost of infection in surgical patients :a-case control study. J Hosp Infect 1993; 25: 239–250.
- French GL, Cheng AFB. Measurement of the costs of hospital infection by prevalence surveys. J Hosp Infect 1991; 18, Suppl A: 65-72.
- Mehtar S. How to cost and fund an infection control programme. J Hosp Infect 1993; 25: 57–69.
- Spengler RF, Greenough WB. Hospital costs and mor-tality attributed to nosocomial bacteremias. JAMA 1978; 240, 22: 2455–8.
- Kerr JR, Borr JG, Smyth ETM, O'Hare J. Technique for calculation of the true costs of antibiotic therapy. Eur J Clin Microbiol Infect Dis 1992; 11, 9: 823–7.
- Drummond MF, Davies LM. Evaluation of the costs and benefits of reducing hospital infection. J Hosp Infect 1991; 18, Suppl A: 85-93.
- Chaudhuri AK. Infection control in hospitals: has its quality-enhancing and cost effective role been appreciated? J Hosp Infect 1993; 25: 1–6.
- Davey P, Hemanz C, Lynch W, Malek M, Byrne D. Human and non-financial costs of hospital acquired infection. J Hosp Infect 1991; 18, Suppl A: 79-84.
- Haley RW, Schaberg Dr. Van Allmen SD, McGowen JE. Estimating the extra charges and prolongation of hospital-ization due to nosocomial infections: A comparison of meth-ods. J Infect Dis 1980; 14: 248–257.
- Haley RW, Culver DH, White JW, Morgon WM, Emori TG. The nationwide nosocomial infection rate. A new need for vital statistics. Am J Epidemiol 1985; 121, 2: 159–167.
- Kereselidze T, Maglacas AM. Nosocomial infections-what WHO is doing. J Hosp Infect 1984; 5, Suppl A: 7-11.
- Haley RW, Schaberg DR, Crossley KB, Von Allman SD, McGowen JE. Extra charges and prolongation of stay attributable to nosocomial infections: A prospective interhos-pital comparison. Am J Med 1981; 70: 51–8.
- Mayon-White RT, Ducel G, Kereselidze T, Tikomirov E. An international survey of the prevalence of hospital-acquired infection. J Hosp Infect 1988; 11, Suppl.A: 43-8.
- Westwood JCN, Legrace S, Mitchell MA. Hospital-acquired infection: Present and future impact and need for positive action. Can Med Assoc J 1974; 110: 769–774.
- Tess Bh, Glenister HM, Rodrigues LC, Wagner MB. Incidence of hospital acquired infection and length of hospi-tal stay. Eur J Clin Microbiol Infect Dis 1993; 12, 2: 81–6.
- Daschner F. Cost effectivenes in hospital infection con-trol-lessons for the 1990s. J Hosp Infect 1989; 13: 325–336.
- Gross PA, Antwergen CV. Nosocomial infections and hospital deaths. A case-control study. Am J Med 1983; 75: 658–662.
- Dinkel RH, Lebok V. A survey of nosocomial infec-tions and their influence on hospital mortality rates. J Hosp Infect 1994; 28: 297–304.
- Gross PA, Neu HC, Aswapokee P, Antwerpen CV, Aswapokee N. Deaths from nosocomial infections: Experience in a University Hospital and a Community Hospital. Am J Med 1980; 68: 219–223.
- Haley RW, Culver Dh, White JW, Morgan WM, Emori TG, Munn VP, Hooton TM. The efficacy of infection surveillance and control programs in preventing nosocomial infections in US Hospitals. Am J Epidemiol 1985; 121: 182–205.